All Stories

  1. Evaluation of pharmacokinetic pharmacodynamic target attainment of meropenem in pediatric patients
  2. Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia
  3. Cross-national comparative study of orphan drug policies in Saudi Arabia, the United States, and the European Union
  4. Population Pharmacokinetics of Rivaroxaban in Real‐World Patients
  5. Assessment of Micafungin Dosage Regimens in Patients with Cancer Using Pharmacokinetic/Pharmacodynamic Modeling and Monte Carlo Simulation
  6. Sinapic acid mitigates methotrexate‐induced hepatic injuries in rats through modulation of Nrf‐2/ HO ‐1 signaling
  7. Estimation of Tacrolimus Clearance in Saudi Adult Kidney Transplant Recipients
  8. Multi-Therapeutic Potential of Naringenin (4′,5,7-Trihydroxyflavonone): Experimental Evidence and Mechanisms
  9. Optimization of Vancomycin Dosing Regimen in Cancer Patients using Pharmacokinetic/Pharmacodynamic Modeling
  10. Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia
  11. Drug utilization and expenditure of anticancer drugs for breast cancer
  12. Estimation of lithium clearance in patients with bipolar disorder
  13. Gender effect on the pharmacokinetics of thymoquinone: Preclinical investigation and in silico modeling in male and female rats
  14. Appropriate therapeutic drug monitoring of antibiotics contributed to lower nephrotoxicity
  15. Exploring the value of a Doctor of Philosophy program in Pharmaceutical Outcomes and Policy Research in Saudi Arabia
  16. Antidiabetic, antioxidant, molecular docking and HPTLC analysis of miquelianin isolated from Euphorbia schimperi C. Presl
  17. Estimation of apparent clearance of valproic acid in adult Saudi patients
  18. Estimation of Phenytoin Pharmacokinetic Parameters in Saudi Epileptic Patients
  19. Optimizing Vancomycin Monitoring in Pediatric Patients
  20. An update on the potential role of intestinal first-pass metabolism for the prediction of drug–drug interactions: the role of PBPK modeling
  21. Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo
  22. Population Pharmacokinetic Model for Vancomycin Used in Open Heart Surgery: Model-Based Evaluation of Standard Dosing Regimens
  23. Optimizing Amikacin Dosage in Pediatrics Based on Population Pharmacokinetic/Pharmacodynamic Modeling
  24. Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass
  25. In silico ADME-Tox modeling: progress and prospects
  26. Thiazole-valine peptidomimetic (TTT-28) antagonizes multidrug resistance in vitro and in vivo by selectively inhibiting the efflux activity of ABCB1
  27. Transporters as Drug Targets in Neurological Diseases
  28. PEGylation Enhances the Oral Bioavailability of γ-Tocotrienol Isomer of Vitamin E
  29. Development of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model to Predict the Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics Represented by Receptor/Transporter Occupancy of Central Nervous System Drugs
  30. Development of a physiologically based pharmacokinetic/pharmacodynamic model to identify mechanisms contributing to entacapone low bioavailability
  31. Extra-virgin olive oil attenuates amyloid-β and tau pathologies in the brains of TgSwDI mice
  32. Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in Pregnancy
  33. PEGylated γ-tocotrienol isomer of vitamin E: Synthesis, characterization, in vitro cytotoxicity, and oral bioavailability
  34. Orlistat limits cholesterol intestinal absorption by Niemann-pick C1-like 1 (NPC1L1) inhibition
  35. Cellular uptake, antioxidant and antiproliferative activity of entrapped α-tocopherol and γ-tocotrienol in poly (lactic-co-glycolic) acid (PLGA) and chitosan covered PLGA nanoparticles (PLGA-Chi)
  36. ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel
  37. Vitamin E Transporters in Cancer Therapy
  38. The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study
  39. Enhanced Solubility and Oral Bioavailability of γ‐Tocotrienol Using a Self‐Emulsifying Drug Delivery System (SEDDS)
  40. Effect of PEG Surface Conformation on Anticancer Activity and Blood Circulation of Nanoemulsions Loaded with Tocotrienol-Rich Fraction of Palm Oil
  41. Experimental models for predicting drug absorption and metabolism
  42. Nonlinear Absorption Kinetics of Self-Emulsifying Drug Delivery Systems (SEDDS) Containing Tocotrienols as Lipophilic Molecules: In Vivo and In Vitro Studies